Cite
Jiang MY, Han ZD, Li W, et al. Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation. Oncotarget. 2017;8(46):80295-80302doi: 10.18632/oncotarget.17927.
Jiang, M. Y., Han, Z. D., Li, W., Yue, F., Ye, J., Li, B., Cai, Z., Lu, J. M., Dong, W., Jiang, X., Zhong, W., He, H., & Liu, L. (2017). Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation. Oncotarget, 8(46), 80295-80302. https://doi.org/10.18632/oncotarget.17927
Jiang, Min-Yao, et al. "Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation." Oncotarget vol. 8,46 (2017): 80295-80302. doi: https://doi.org/10.18632/oncotarget.17927
Jiang MY, Han ZD, Li W, Yue F, Ye J, Li B, Cai Z, Lu JM, Dong W, Jiang X, Zhong W, He H, Liu L. Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation. Oncotarget. 2017 May 17;8(46):80295-80302. doi: 10.18632/oncotarget.17927. eCollection 2017 Oct 06. PMID: 29113303; PMCID: PMC5655198.
Copy
Download .nbib